Julphar Bangladesh Ltd. Julphar Bangladesh Ltd.

Julphar Bangladesh Launched- Daclacee (first time in Bangladesh)

To extend the horizon of Antiviral treatment Julphar Bangladesh has launched another breakthrough Antiviral product Daclacee (Daclatavir 60 mg) first time in Bangladesh.

  • Provide Pangenotypic anti-HCV activity
  • High SVR rate
  • Less treatment duration and cost
  • Convenient oral treatment regimen

Daclacee (Daclatasvir 60 mg) tablet can be taken orally once daily with Hepcee (Sofosbuvir 400 mg), if needed weight based Ribavirin (800 mg to 1200 mg/day) can be added. Treatment should be continued 12 or 24 weeks based on HCV genotype & disease stage.
Daclacee is the Antiviral drug for all genotypes and for all cases.


Last Update: 23 Jan 2018

© Julphar Bangladesh Ltd. 2008 - 2018. All Rig hts Reserved.
Developed By : Alien BD Inforamtion & Technology